The global pneumonia testing market size hit USD 557.1 million in 2021. The market valuation is slated to rise from USD 606.6 million in 2022 to USD 912.5 million by 2029, recording 6% CAGR during 2022-2029. This information is provided by Fortune Business Insights in its report titled “Pneumonia Testing Market, 2022-2029”. Request a Sample Copy of the Research Report: Regional Insights: The North American Market Stood at USD 221.4 Million in 2021 North America dominated the pneumonia testing market share in 2021 with USD 221.4 million. The region will continue to hold the dominant market share through 2029 led by growing pneumonia cases, rapid adoption of point-of-care technologies, and supportive reimbursement policies. The European market holds the second-largest market share and will experience growth led by growing number of hospital admissions related to pneumonia. Meanwhile, the market in Asia Pacific will grow on account of a large geriatric population. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: COVID-19 Impact: Viral Pneumonia Cases Surged While Community-acquired Cases Dropped during Pandemic     The COVID-19 pandemic had a dual impact on the pneumonia testing market growth. An increase in viral pneumonia cases was seen during the pandemic. This increased the number of microbiological tests performed on individuals with COVID-19-induced pneumonia to check for co-infection. However, due to stringent lockdown guidelines, the incidence of community-acquired pneumonia decreased. About Us: Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in. Contact Us: Fortune Business Insights™ Pvt. Ltd. Pune – 411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: [email protected]